An open, multicenter, single dose, parallel study, evaluating the pharmacokinetics of doxorubicin and its active metabolite (doxorubicinol) after a hepatic intra-arterial injection of either a lipiodol emulsion containing doxorubicin or doxorubicin loaded into DC Beads in patients with intermediate stage hepatocellular carcinoma (HCC).
Phase of Trial: Phase IV
Latest Information Update: 12 Aug 2013
Price : $35 *
At a glance
- Drugs Doxorubicin (Primary) ; Ethiodized oil
- Indications Liver cancer
- Focus Pharmacokinetics
- 12 Aug 2013 Planned End Date changed to 23 Jul 2015.
- 12 Aug 2013 New trial record